福安药业12月29日获融资买入1057.56万元，融资余额4.23亿元

Core Viewpoint - Fuan Pharmaceutical experienced a decline in stock price and significant changes in financing activities, indicating potential liquidity concerns and market sentiment shifts [1][2]. Financing Activities - On December 29, Fuan Pharmaceutical's stock fell by 0.45%, with a trading volume of 59.87 million yuan. The financing buy-in amounted to 10.58 million yuan, while financing repayment was 10.33 million yuan, resulting in a net financing buy of 0.25 million yuan [1]. - As of December 29, the total financing and securities balance for Fuan Pharmaceutical was 423 million yuan, representing 7.98% of its market capitalization. This financing balance is above the 80th percentile of the past year, indicating a high level of leverage [1]. - In terms of securities lending, on the same day, Fuan Pharmaceutical repaid 37,700 shares and sold 500 shares, with a selling amount of 2,225 yuan. The remaining securities lending volume was 29,600 shares, with a balance of 131,700 yuan, also above the 90th percentile of the past year [1]. Company Overview - Fuan Pharmaceutical, established on February 25, 2004, and listed on March 22, 2011, is located in Yubei District, Chongqing. The company primarily engages in the research, production, and sales of antibiotic raw materials and formulations [1]. - The revenue composition of Fuan Pharmaceutical includes 56.60% from formulations, 39.44% from raw materials and intermediates, 3.55% from other sources, and 0.41% from drug distribution and other activities [1]. Shareholder Information - As of December 19, Fuan Pharmaceutical had 42,600 shareholders, an increase of 9.61% from the previous period. The average circulating shares per person decreased by 8.77% to 22,737 shares [2]. - For the period from January to September 2025, Fuan Pharmaceutical reported a revenue of 1.315 billion yuan, a year-on-year decrease of 34.08%, and a net profit attributable to shareholders of 166 million yuan, down 44.87% year-on-year [2]. - Since its A-share listing, Fuan Pharmaceutical has distributed a total of 688 million yuan in dividends, with 202 million yuan distributed over the past three years [2].